Normal Laboratory Reference Intervals among Healthy Adults Screened for a HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana

• Tebogo M. Segolodi ,

  * E-mail: hor9@cdc.gov

  Affiliation United States Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana

  ⨯
• Faith L. Henderson,

  Affiliation United States Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana

  ⨯
• Charles E. Rose,

  Affiliation United States Centers for Disease Control and Prevention Atlanta, Atlanta, Georgia, United States of America

  ⨯
• Kyle T. Turner,

  Affiliation ICF International, Atlanta, Georgia, United States of America

  ⨯
• Clement Zeh,

  Affiliation United States Centers for Disease Control and Prevention Kenya (CDC-Kenya), Kisumu, Kenya

  ⨯
• Peter N. Fonjungo,

  Affiliations United States Centers for Disease Control and Prevention Botswana (CDC Botswana), Gaborone, Botswana, United States Centers for Disease Control and Prevention Atlanta, Atlanta, Georgia, United States of America

  ⨯
• Richard Niska,

  Affiliation United States Centers for Disease Control and Prevention Atlanta, Atlanta, Georgia, United States of America

  ⨯
• Clyde Hart,

  Affiliation United States Centers for Disease Control and Prevention Atlanta, Atlanta, Georgia, United States of America

  ⨯
• Lynn A. Paxton

  Affiliation United States Centers for Disease Control and Prevention Atlanta, Atlanta, Georgia, United States of America

  ⨯